Johan Palm

727 total citations
11 papers, 418 citations indexed

About

Johan Palm is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Johan Palm has authored 11 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pediatrics, Perinatology and Child Health and 3 papers in Infectious Diseases. Recurrent topics in Johan Palm's work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Drug Solubulity and Delivery Systems (3 papers). Johan Palm is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Drug Solubulity and Delivery Systems (3 papers). Johan Palm collaborates with scholars based in Sweden, United Kingdom and United States. Johan Palm's co-authors include Per Artursson, Christel A. S. Bergström, Daniel A.J. Bow, Dietrich Keppler, Yurong Lai, Keith Hoffmaster, Yaofeng Cheng, Raymond Evers, Kim L. R. Brouwer and Bruno Stieger and has published in prestigious journals such as Pharmaceutical Research, Clinical Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.

In The Last Decade

Johan Palm

11 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Palm Sweden 8 337 193 150 77 55 11 418
Saki Izumi Japan 10 385 1.1× 198 1.0× 192 1.3× 66 0.9× 80 1.5× 13 467
Daniel A.J. Bow United States 12 407 1.2× 226 1.2× 191 1.3× 106 1.4× 74 1.3× 17 604
Chenxi Xia China 5 270 0.8× 124 0.6× 102 0.7× 113 1.5× 47 0.9× 14 418
Yaofeng Cheng United States 10 394 1.2× 238 1.2× 165 1.1× 110 1.4× 49 0.9× 17 570
Kristin Westphal Germany 5 285 0.8× 210 1.1× 144 1.0× 67 0.9× 44 0.8× 6 406
Jeevan Kunta United States 9 389 1.2× 202 1.0× 147 1.0× 104 1.4× 80 1.5× 12 519
Danilo Wegner Germany 12 328 1.0× 198 1.0× 123 0.8× 120 1.6× 91 1.7× 19 582
Gunilla Englund Sweden 6 436 1.3× 207 1.1× 124 0.8× 109 1.4× 66 1.2× 6 608
Émilie Jigorel France 6 410 1.2× 165 0.9× 250 1.7× 115 1.5× 46 0.8× 6 593
Dominic Surry United Kingdom 16 354 1.1× 169 0.9× 269 1.8× 146 1.9× 68 1.2× 19 639

Countries citing papers authored by Johan Palm

Since Specialization
Citations

This map shows the geographic impact of Johan Palm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Palm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Palm more than expected).

Fields of papers citing papers by Johan Palm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Palm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Palm. The network helps show where Johan Palm may publish in the future.

Co-authorship network of co-authors of Johan Palm

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Palm. A scholar is included among the top collaborators of Johan Palm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Palm. Johan Palm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Engman, Helena, Sara Carlert, Richard A. Barker, et al.. (2025). Leveraging Biopharmaceutics Bridging Risk Assessment and In Vivo Predictive Tools to Accelerate Immediate Release Drug Product Development by Minimized Need for Clinical Bridging Studies. Molecular Pharmaceutics. 22(10). 6203–6214. 1 indexed citations
2.
Jacobsen, Ann-Christin, et al.. (2022). Intrinsic lipolysis rate for systematic design of lipid-based formulations. Drug Delivery and Translational Research. 13(5). 1288–1304. 4 indexed citations
3.
Johansson, Susanne, David P. Rosenbaum, Johan Palm, et al.. (2017). Tenapanor administration and the activity of the H+‐coupled transporter PepT1 in healthy volunteers. British Journal of Clinical Pharmacology. 83(9). 2008–2014. 10 indexed citations
4.
Pedersen, Jenny M., et al.. (2017). Substrate and method dependent inhibition of three ABC-transporters (MDR1, BCRP, and MRP2). European Journal of Pharmaceutical Sciences. 103. 70–76. 29 indexed citations
5.
Chappell, Michael J., et al.. (2017). Input Estimation for Extended-Release Formulations Exemplified with Exenatide. Frontiers in Bioengineering and Biotechnology. 5. 24–24. 3 indexed citations
6.
Herédi‐Szabó, Krisztina, Johan Palm, Tommy B. Andersson, et al.. (2013). A P-gp vesicular transport inhibition assay – Optimization and validation for drug–drug interaction testing. European Journal of Pharmaceutical Sciences. 49(4). 773–781. 31 indexed citations
7.
Brouwer, Kim L. R., Dietrich Keppler, Keith Hoffmaster, et al.. (2013). In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development. Clinical Pharmacology & Therapeutics. 94(1). 95–112. 191 indexed citations
8.
Eriksson, Ulf G., Johan Palm, Per Artursson, et al.. (2013). Combined in Vitro–in Vivo Approach To Assess the Hepatobiliary Disposition of a Novel Oral Thrombin Inhibitor. Molecular Pharmaceutics. 10(11). 4252–4262. 13 indexed citations
9.
Miliotis, Tasso, Liaqat Ali, Johan Palm, et al.. (2011). Development of a Highly Sensitive Method Using Liquid Chromatography-Multiple Reaction Monitoring to Quantify Membrane P-Glycoprotein in Biological Matrices and Relationship to Transport Function. Drug Metabolism and Disposition. 39(12). 2440–2449. 30 indexed citations
10.
Karlgren, Maria, Gustav Ahlin, Christel A. S. Bergström, et al.. (2011). In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions. Pharmaceutical Research. 29(2). 411–426. 99 indexed citations
11.
Palm, Johan, et al.. (2010). Effects of Ketoconazole on the In Vivo Biotransformation and Hepatobiliary Transport of the Thrombin Inhibitor AZD0837 in Pigs. Drug Metabolism and Disposition. 39(2). 239–246. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026